Planned and taught by Drs. Andrew Heyman and Ritchie Shoemaker—two of the world's leading experts in biotoxin illness—this workshop explores recent clinical advances in Chronic Inflammatory Response Syndrome (CIRS). Lectures will review revised diagnostic criteria and new insights in NeuroQuant Analysis and evaluate the breakthrough genomic test that distinguishes mold exposure, Lyme disease, post-Lyme syndrome, excess histamine response and cell hypometabolism. The field of genomics is now a central aspect in the diagnosis, assessment, and treatment of this patient population, and the workshop will allow learners the opportunity to apply newly emerging methodologies into practice. Sessions will additionally cover expanded treatment methods and revised clinical protocols in detail, and challenging, complex patient case studies.